Princeton Reimbursement Group (PRG) supports the medical device industry with comprehensive services in the area of Medicare and third-party payer reimbursement. Clients benefit from our extensive knowledge of the changing reimbursement climate in the U.S. PRG provides strategic assessment, clinical trial reimbursement assistance, health economics analyses, outcomes studies, health technology assessments and specialized programs during the entire product development cycle, from concept stage through post-launch. Our goal is to help you increase the potential for positive reimbursement decisions by private and government insurers.
PRG also provides assistance to international companies planning to do business in the U.S. by helping them navigate the complex reimbursement environment.
A comprehensive strategic plan is the crucial first step in proactively addressing reimbursement issues affecting new and existing products.
Pursuing reimbursement during clinical trials can result in the collection of cost-effectiveness data, a charge history and an early revenue stream.
Providing analyses of the value of medical technology is critical for gaining coverage and reimbursement from payers and for supporting sales to healthcare providers and purchasers.
On-going activities such as payer advocacy, interactive payment tools, reimbursement guides and customer advisories, local coverage decision monitoring, reimbursement training, and "hot lines" are designed to enhance the long-term market success of your product.
A thorough assessment of the reimbursement environment for a new technology provides the foundation upon which ultimate market success will be built.